secwatch.observer — SEC 8-K summary
======================================

Issuer:     CME GROUP INC. (CME)
CIK:        0001156375
Form:       8-K
Filed at:   2026-06-17T12:35:53+00:00
Accession:  0001193125-26-273442
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CME Group CEO Terry Duffy to transition to Executive Chairman in March 2027; President & CFO Lynne Fitzpatrick named CEO
--------------------------------------------------------------------------------

- Terrence A. Duffy will become Executive Chairman effective March 1, 2027 (or later when 2026 10-K is filed); he remains CEO until then.
- Lynne C. Fitzpatrick, currently President and CFO, will succeed Duffy as CEO and join the Board on the transition date.
- Fitzpatrick's CEO compensation: $1.2M base salary; annual bonus target 200% of base; LTI target 700% of base.
- Company will conduct a search for a successor to Fitzpatrick as CFO.
- Duffy's transition agreement provides continued base salary, bonus and equity vesting at target through his Executive Chairman term ending Dec 31, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/0001193125-26-273442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156375/000119312526273442/d129556d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-273442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer